Proteases release

These proteins are called acute phase proteins (or reactants) and include C-reactive protein (CRP, so-named because it reacts with the C polysaccharide of pneumococci), ai-antitrypsin, haptoglobin, aj-acid glycoprotein, and fibrinogen. The elevations of the levels of these proteins vary from as little as 50% to as much as 1000-fold in the case of CRP. Their levels are also usually elevated during chronic inflammatory states and in patients with cancer. These proteins are believed to play a role in the body s response to inflammation. For example, C-reactive protein can stimulate the classic complement pathway, and ai-antitrypsin can neutralize certain proteases released during the acute inflammatory state. CRP is used as a marker of tissue injury, infection, and inflammation, and there is considerable interest in its use as a predictor of certain types of cardiovascular conditions secondary to atherosclerosis. Interleukin-1 (IL-1), a polypeptide released from mononuclear phagocytic cells, is the principal—but not the sole—stimulator of the synthesis of the majority of acute phase reactants by hepatocytes. Additional molecules such as IL-6 are involved, and they as well as IL-1 appear to work at the level of gene transcription. 

A rather new development is the orally available renin inhibitor aliskiren. It was approved by the U.S. Food and Drug Administration in 2007 for the treatment of hypertension. As mentioned above renin is a protease released on various stimuli from the jux-taglomerula apparatus in the kidney. Its release is the limiting step in the whole renin-angiotensin cascade. Since renin is highly substrate-specific its inhibition can be expected to have very little unspecific side effects. The result of an effective blockade of this enzyme is a reduced angiotensin I and angiotensin II formation. In contrast to ACE-inhibition or ATi-receptor blockade, the plasma concentrations of both peptides stay low. No interaction with other systems like the Kallikrenin-Bradykinin system seems to take place. 

In the small intestine, proteases released by the pancreas as zymogens become active. Each has a different specificity for the amino acid R-groups adjacent to the susceptible peptide bond. Examples of these enzymes are trypsin, chymotrypsin, elastase, and car-boxypeptidase A and B. The resulting oligopeptides are cleaved by aminopeptidase found on the luminal surface of the intestine. Free amino acids and dipeptides are then absorbed by the intestinal epithelial cells. 

Dalton, J.P. and Heffernan, M. (1989) Thiol proteases released in vitro by Fasciola hepatica. Molecular and Biochemical Parasitology 35, 1 51 -155. 

Neutral and acidic serine proteases released from mast cells-tryptase MCX may damage type IV collagen and the intercellular matrix. Eosinophil chemotactic factors... 

Serine proteases, released from immune cell granules, process cytokines and growth factors that control multiple cellular process [56], Proteinase 3, cathepsin G, and elastase all cleave membrane-bound TNF-o, IL-1, and IL-18, and activate epidermal growth factor receptor (EGFR) and toll-like receptor-4 (TLR-4). These actions inhibit growth and lead to apoptosis with transcriptional nuclear factor kB (NF-kB) inactivation. Bik suppresses release of TNF-o, IL-1, and IL-18 and prevents EGFR and TLR-4 activation. Activation of NF-kB is a mediator of cell proliferation, whereas inhibition of NF-/. B leads to apoptosis [82]. Overall, Bik inhibition of immune cell serine proteases increases cell proliferation and stability. 

Leukocytes, macrophages, and mast cells are observed at one stage or another of most inflammatory diseases. All of these cells are rich in proteases and are important mediators of allergic, infective, and anaphylactic reactions of tissues in most animals. It is likely that proteases released from these cells contribute to the inflammatory process by degrading connective tissue components and by releasing kinins. 

To isolate a functional macromolecular component from bacterial cells, you must accomplish three things. First, you must efficiently disrupt the bacterial cell wall and cell-membrane system to facilitate extraction of desired components. Second, you must work under conditions that either inhibit or destroy the many degradative enzymes (nucleases, proteases) released during cell disruption. Finally, you must employ a fractionation procedure that separates the desired macromolecule from other cellular components in satisfactory yield and purity. 

Higuchi, K., Kajiki, A., Nakamura, M., Harada, S., Pula, P.J., Scott, A.L., Dannenberg, A.M., Jr. (1988). Proteases released in organ culture by acute dermal inflammatory lesions produced in vivo in rabbit skin by sulfur mustard hydrolysis of synthetic peptide substrates for trypsin-like and chymotrypsin-like enzymes. Inflammation 12 311-34. 

Figure 2 Bacillus subtiHs S2P-like protease SpolVFB and sporulation. When the mother cell engulfs the forespore, a signaling pathway that involves the transcription factor is initiated in the forespore that triggers the synthesis of the IVB serine protease. This protease degrades SpolVFA, which along with BofA serves to inhibit SpolVFB. With the inhibition of the S2P-like protease released, SpolVFB cleaves pro-c, which allows this transcription factor to signal in the mother cell for more factors needed for spore maturation.

Gentle Cell lysis (osmotic shock) 2 volumes water to 1 volume packed pre-washed cells erythrocytes E.coli periplasm intracellular proteins lower product yield but reduced protease release... 

Sucrose or glucose 25 mM stabilise lysosomal membranes, reduce protease release... 

Any of several mechanisms can activate complement, including continuous and spontaneous tickover, activation of the classical pathway (e.g., by the antigen antibody complexes or CRP), activation of the alternative pathway, and action of proteases released by leukocytes and other inflammatory cells. The common step involved in aU of these is the conversion of C3 to C3b, as shown in Figure 20-7. This figure also demonstrates the sites of action of the inhibitors and inactivators of complement (shown in gray shading), which prevent excessive or continuous depletion of the complement components in addition to controlling complement activity in sites of inflammation. 

Proteases released during the infection process may lead to protein inhomogeneities and product degradation [4, 5]. Several baculovims-encoded proteases and chitinases have heen identified which, upon insect larvae infection, induce hque-faction of the infected host ]44, 45]. The cysteine protease v-cath identified in A. ca-lifornica shows functional homologies to mammahan cathepsin L ]46]. Several studies have focused on the neutrahzation of... 

Sauer A, Hartung T, Aigner J, Wendel A (1996) Endotoxin-inducible granulocyte-mediated hepatotoxicity requires adhesion and serine protease release. J Leukoc Biol 60 633-643... 

---